Medtronic Bakken Research Center B.V. – Trademark Portfolio

Entity Type: 99

Medtronic Bakken Research Center B.V. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include SURETUNE. The owner is based in Maastricht.

Endepolsdomein 5

Maastricht 6229GW , NL

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SURETUNE
SURETUNE
Registered 2021
SURETUNE
SURETUNE
Registered 2018

Trademark Classifications

Medtronic Bakken Research Center B.V.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Medtronic Bakken Research Center B.V. have?

Medtronic Bakken Research Center B.V. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Medtronic Bakken Research Center B.V. file in?

Medtronic Bakken Research Center B.V. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Medtronic Bakken Research Center B.V.'s most well-known trademarks?

Medtronic Bakken Research Center B.V.'s registered trademark portfolio includes well-known marks such as SURETUNE. These are among 2 currently registered trademarks in the portfolio.

What is Medtronic Bakken Research Center B.V.'s trademark registration success rate?

Medtronic Bakken Research Center B.V. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.